cancer weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of cancer weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccine
Mono-epitopic peptide-based vaccine induces regression of liver tumor
December 14th, 2004
Mono-epitopic peptide-based immunotherapy induced regression of an established liver tumor. According to recent research published in the Journal of Immunology, "Most types of cancer are difficult to eradicate, and some, like hepatocellular carcinoma, are almost always fatal. Among various interventions to improve the survival of patients with cancer, immunotherapy seems to hold some promises. However, it requires relevant animal models for preclinical development. In this study we report a new and relevant experimental model where liver tumors grow inside a nontumoral parenchyma of adult mice." "This model is based on the intrasplenic...
Source: cancer weekly (2004-12-14)
|
